The company moves ahead on its leukemia treatment, after encouraging study results.
The industrially useful marijuana relative has been banned for decades, but Colorado has opened the door to legal farming again.
While many US facilities get top ratings, the most common is a C, and major improvements have been slow in coming.
A string of serious setbacks for possible treatments may be eroding researchers' -- and investors' -- confidence.
The supplement has no heart benefits for patients, which doesn't bode well for the drug company's efforts to market Vascepa.
The edgy accessories are sparking more controversy for the envelope-pushing retailer. Will that help or hurt its sales?
This speculative drug stock is targeting the growing global problem of hospital-based infections.
In an industry first, the drug giant will sell directly to consumers via its website. It probably won't be the only one to try this.
VIDEO ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
TOP STOCKS
Global markets reacted to the mixed message from the Fed by selling. But there is indication of another rally phase ahead..
MARKET DISPATCHES
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
FRUGAL COOL
Starting Monday, this site is joining forces with MSN Money Smart Spending. Here's why.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
SMART SPENDING
Yes, sometimes retail therapy has a place. Just try to be aware of shopping to beat the blues, and don't overspend.
SMART TAXES
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.
